Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 6 Bayesian analysis of Stroke Prevention Using Oral Thrombin Inhibitor in Atrial Fibrillation (SPORTIF) V trial. Tri-plots showing posterior (thick line) distributions derived from integrating evidence or likelihood (thin line) from SPORTIF V trial and three different priors (dashed line), according to Bayes' theorem. The margin of non-inferiority (M) is indicated by the two vertical dotted lines and is equivalent to a log risk ratio of 0.5 (equivalent to a risk ratio of 1.65). Three priors are used: 1) uninformative prior, intended to add as little as possible to the data (formally expressed as log-RR mean (µ) = 0, standard deviation ({sigma}) = 10; likelihood and posterior distributions are superimposed, hence only one plot); 2) moderately skeptical (i.e., 50% of the distribution is contained within the non-inferiority margin [log-RR µ = 0.250, {sigma} = 0.374]); and 3) informative, on the basis of prior information derived from SPORTIF III trial (log-RR µ = –0.338, {sigma} = 0.241). Posterior probability of any effect size can be calculated by computing area under the curve. The probabilities of falling below (<M), within (= M), or above M (>M) are shown on the top right-hand corner of each plot. Probability of non-inferiority is computed as the sum of probability of <M plus = M (e.g., the posterior probability of non-inferiority with uninformative prior [plot # 1] is 0.068 [<M] + 0.736 [= M] = 0.804). Non-inferiority is inferred at a posterior probability of ≥0.975 (corresponding to a one-sided p ≤ 0.025).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement